Sort by
Items per page

Send to

Choose Destination

Search results

Items: 10


RCAN1.4 regulates VEGFR-2 internalisation, cell polarity and migration in human microvascular endothelial cells.

Alghanem AF, Wilkinson EL, Emmett MS, Aljasir MA, Holmes K, Rothermel BA, Simms VA, Heath VL, Cross MJ.

Angiogenesis. 2017 Aug;20(3):341-358. doi: 10.1007/s10456-017-9542-0. Epub 2017 Mar 7.


Relative expression of vascular endothelial growth factor isoforms in squamous cell carcinoma of the head and neck.

Wilkie MD, Emmett MS, Santosh S, Lightbody KA, Lane S, Goodyear PW, Sheard JD, Boyd MT, Pritchard-Jones RO, Jones TM.

Head Neck. 2016 May;38(5):775-81. doi: 10.1002/hed.23959. Epub 2015 May 26.


Angiogenesis and melanoma - from basic science to clinical trials.

Emmett MS, Dewing D, Pritchard-Jones RO.

Am J Cancer Res. 2011;1(7):852-68. Epub 2011 Aug 8.


CCR7 mediates directed growth of melanomas towards lymphatics.

Emmett MS, Lanati S, Dunn DB, Stone OA, Bates DO.

Microcirculation. 2011 Apr;18(3):172-82. doi: 10.1111/j.1549-8719.2010.00074.x.


Chemotrap-1: an engineered soluble receptor that blocks chemokine-induced migration of metastatic cancer cells in vivo.

Lanati S, Dunn DB, Roussigné M, Emmett MS, Carriere V, Jullien D, Budge J, Fryer J, Erard M, Cailler F, Girard JP, Bates DO.

Cancer Res. 2010 Oct 15;70(20):8138-48. doi: 10.1158/0008-5472.CAN-10-0175. Epub 2010 Aug 24.


Prediction of melanoma metastasis by the Shields index based on lymphatic vessel density.

Emmett MS, Symonds KE, Rigby H, Cook MG, Price R, Metcalfe C, Orlando A, Bates DO.

BMC Cancer. 2010 May 17;10:208. doi: 10.1186/1471-2407-10-208.


Chemokine-mediated migration of melanoma cells towards lymphatics--a mechanism contributing to metastasis.

Shields JD, Emmett MS, Dunn DB, Joory KD, Sage LM, Rigby H, Mortimer PS, Orlando A, Levick JR, Bates DO.

Oncogene. 2007 May 10;26(21):2997-3005. Epub 2006 Nov 27.


Abdominal complications after heart surgery.

Khan JH, Lambert AM, Habib JH, Broce M, Emmett MS, Davis EA.

Ann Thorac Surg. 2006 Nov;82(5):1796-801.


VEGF-C promotes survival in podocytes.

Foster RR, Satchell SC, Seckley J, Emmett MS, Joory K, Xing CY, Saleem MA, Mathieson PW, Bates DO, Harper SJ.

Am J Physiol Renal Physiol. 2006 Jul;291(1):F196-207. Epub 2006 Mar 8.


The sialomucin CD34 is a marker of lymphatic endothelial cells in human tumors.

Fiedler U, Christian S, Koidl S, Kerjaschki D, Emmett MS, Bates DO, Christofori G, Augustin HG.

Am J Pathol. 2006 Mar;168(3):1045-53.

Supplemental Content

Loading ...
Support Center